Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Quantum Leap Healthcare Collaborative Announces AstraZeneca’s Olaparib And Durvalumab‎ For The I-SPY 2 Trial For Breast Cancer

Quantum Leap Healthcare Collaborative™ (QLHC) announced that a new randomized, investigational treatment arm for the I-SPY 2 TRIAL™ includes the study of olaparib and durvalumab, two agents from AstraZeneca.

Related Posts
1 of 2

Olaparib is a poly (ADP-ribose) polymerase (PARP) enzyme inhibitor and durvalumab is an anti-PD-L1 monoclonal antibody immunotherapy agent. Olaparib and durvalumab in combination with paclitaxel (chemotherapy) treatment will be compared to standard therapy (paclitaxel) alone in the new I-SPY 2 TRIAL treatment arm. Patients with HER2 negative breast cancer who are eligible to participate in the trial will be adaptively randomized into the olaparib/durvalumab/paclitaxel arm, another investigational arm, or standard of care (paclitaxel). Patients will then continue treatment with doxorubicin/cyclophosphamide (AC) regardless of assigned arm, all taking place in the neoadjuvant setting (treatment and/or chemotherapy prior to surgery).

Read More: The Promise and Potential of AI for the Insurance Industry

The I-SPY 2 TRIAL, sponsored by QLHC, is a standing phase 2 randomized, controlled, multicenter study with an innovative Bayesian adaptive design aimed to rapidly screen and identify promising new treatments in specific subgroups of women with newly-diagnosed, high-risk (high likelihood of recurrence), locally-advanced breast cancer (Stage II/III). Quantum Leap Healthcare Collaborative (QLHC) is a 501C(3) charitable organization established in 2005 as a collaboration between medical researchers at University of California, San Francisco and Silicon Valley entrepreneurs.

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three main therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory.

Read More: Interview with David Sikora, Chief Executive Officer at ALTR

 

13 Comments
  1. fantastic put up, very informative. I’m wondering why the other specialists of this
    sector do not realize this. You must continue your writing.
    I’m sure, you’ve a huge readers’ base already!

  2. Compra diodex 4 mg en España says

    Thank you for the auspicious writeup. It in fact was a amusement account it.

    Look advanced to far added agreeable from you! However, how could we communicate?

  3. prezzo accessibile per ciflox says

    It’s difficult to find knowledgeable people for this topic, but you sound like you know what you’re talking about!
    Thanks

  4. Hi, i think that i saw you visited my website so i came to “return the favor”.I’m trying to find things to improve my web site!I suppose
    its ok to use some of your ideas!!

  5. Christopher says

    Hi there to all, the contents existing at this website are truly remarkable for people experience, well,
    keep up the good work fellows.

  6. Fastidious respond in return of this issue with real arguments and describing everything
    on the topic of that.

  7. Having read this I believed it was very enlightening. I appreciate you finding the time and effort to put this short
    article together. I once again find myself spending way too
    much time both reading and posting comments. But so what, it was still worthwhile!

  8. Fidelia says

    I need to to thank you for this good read!! I definitely loved every bit of it.
    I’ve got you book-marked to look at new stuff
    you post…

  9. Hello colleagues, its fantastic post about educationand entirely
    explained, keep it up all the time.

  10. hipokinon en vente en Espagne says

    Fine way of explaining, and good post to obtain facts
    regarding my presentation topic, which i am going to deliver in university.

  11. Iron waste reuse says

    Metal residue recycling Ferrous material digital presence Iron waste disposal site

    Ferrous metal recycling equipment, Iron waste reclamation and recovery, Metal waste disposal yard

  12. Copper scrap payment terms says

    Scrap Copper recycling process Copper scrap recycling plant Scrap metal analysis
    Recycling facilities for Copper cable scrap, Metal reclaiming and recycling solutions, Industrial copper salvage

  13. Metal recycling certification Ferrous scrap export Scrap iron yard

    Ferrous material efficiency, Iron scrap removal, Scrap metal reconditioning and reusing

Leave A Reply

Your email address will not be published.